US approval for drug that turns herpes virus against cancer
by Associated Press in Washington from on (#RTR8)
Imlygic, which bursts melanoma cells open and triggers immune response, can shrink localised tumours but is not proven to extend life, says FDA
The US Food and Drug Administration has approved a first-of-a-kind drug that uses the herpes virus to infiltrate deadly skin cancer tumours, reducing their size in some cases.
Related: The Guardian view on meat and cancer: a little of what you fancy will do you no harm | Editorial
Continue reading...